Canine visceral leishmaniasis and its emergence in the United States

Veterinary Clinics of North America - Small Animal Practice

Volumn 33, Issue 4, 2003, Pages 921-937

  Rosypal, Alexa C ^a   Zajac, Anne M ^a   Lindsay, David S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; MEGLUMINE ANTIMONATE; PAROMOMYCIN; PENTAMIDINE; STIBOGLUCONATE SODIUM;

DIAGNOSTIC PROCEDURE; DISEASE CARRIER; DOG; FLY; HOST; HUMAN; IMMUNITY; INSECT; LEISHMANIA INFANTUM; NONHUMAN; PUBLIC HEALTH; REVIEW; UNITED STATES; VETERINARY MEDICINE; VISCERAL LEISHMANIASIS; ZOONOSIS;

CANIS FAMILIARIS; INSECTA; LEISHMANIA INFANTUM;

EID: 0041695281     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(03)00030-5     Document Type: Review

References (69)

1. Reithinger R, Davies CR. 2002. Canine leishmaniasis: novel strategies for control. Trends Parasitol 2002;18(7):289-90.
2. Ashford DA, David JR, Freire M, David R, Sherlock I, Eulalio MC, et al. Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg 1998;59(1):53-7.
3. Gavgani AS, Mohite H, Edrissian GH, Mohebali M, Davies CR. Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum. Am J Trop Med Hyg 2002;67(5):511-5.
4. Mauricio IL, Howard MK, Stothard JR, Miles MA. Genomic diversity in the Leishmania donovani complex. Parasitology 1999;119(3):237-46.
5. Gaskin AA, Schantz P, Jackson J, Birkenheuer A, Tomlinson L, Gramiccia M, et al. Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 2002;16(1):34-44.
6. Moreno J, Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol 2002;18(9):399-405.
7. Lindsay DS, Zajac AM, Barr SC. Canine leishmaniasis in American foxhounds. An emerging zoonosis? Comp Cont Ed Prac Vet 2002;24(4):304-12.
8. Enserink M. Infectious diseases. Has leishmaniasis become endemic in the United States? Science 2000:290(5498):1881-3.
9. Lane RP. Sand flies (Phlebotominae). In: Lane RP, Crosskey RW, editors. Medical insects and arachnids. 1st edition. New York: Chapman and Hall; 1993. p. 78-119.
10. Killick-Kendrick R. The biology and control of Phlebotomine sand flies. Clin Dermatol 1999;17(3):279-89.
11. Schlein YS, Jacobson RL, Messer G. Leishmania infections damage the feeding mechanism of the sand fly vector and implement parasite transmission by bite. Proc Natl Acad Sci U S A 1992;89(20):9944-8.
12. Tesh RB, Guzman H. Sand flies and the agents they transmit. In: Beaty BJ, Marquardt WC, editors. The biology of disease vectors. Niwot (CO): University Press of Colorado; 1996. p. 117-27.
13. Young DG, Perkins PV. Phlebotomine sand flies of North America (Diptera:Psychodidae). Mosq News 1984;44(2):264-304.
14. Travi BL, Cerro C, Cadena H, Montoya-Lerma J, Adler GH. Canine visceral leishmaniasis: dog infectivity to sand flies from nonendemic areas. Res Vet Sci 2002; 72(1):83-6.
15. McHugh CP, Ostrander BF, Raymond RW, Kerr SF. Population dynamics of sand flies (Diptera:Psychodidae) at two foci of leishmaniasis in Texas. J Med Entomol 2001; 38(2):268-77.
16. Nuvayri-Salti N, Fallah-Kansa, H. Direct no-insect-vector transmission of Leishmania parasites in mice. Int J Parasitol 1985;15(5):497-500.
17. Owens SD, Oakley DA, Marryott K, Hatchett W, Walton R, Nolan TJ, et al. Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs. J Am Vet Med Assoc 2001;219(8):1076-83.
18. Giger U, Oakley DA, Owens SD, Schantz P. Leishmania donovani transmission by packed RBC transfusion to anemic dogs in the United States. Transfusion 2002;42(3):381-3.
19. Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999; 104(5):e65.
20. Mancianti F, Sozzi S. Isolation of Leishmania from a newborn puppy. Trans Royal Soc Trop Med Hyg 1995;89(4):402.
21. Andrade HM, de Toledo Vde P, Marques MJ, Franca Silva JC, Tafuri WL, Mayrink W, et al.. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Vet Parasitol 2002;103(1-2):71-81.
22. Solano-Gallego L, Llull J, Ramos G, Riera C, Arboix M, Alberola J, et al. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet Parasitol 2000;90(1-2):37-45.
23. Franca-Silva JC, da Costa RT, Siqueira AM, Machado-Coelho GL, da Costa CA, Mayrink W, et al. Epidemiology of canine visceral leishmaniasis in the endemic area of Montes Claros Municipality, Minas Gerais state, Brazil. Vet Parasitol 2003;111: 161-73.
24. Ferrer LM. Clinical aspects of canine leishmaniasis. In: Killick-Kendrick R, editor. Canine leishmaniasis: an update. Proceedings of the International Canine Leishmania Forum. Barcelona (Spain): Hoechst Roussel Vet.; 1999. p. 6-10.
25. Blavier A, Keroack S, Denerolle P, Goy-Thollot I, Chabanne L, Cadore JL, et al. Atypical forms of canine leishmaniasis. Vet J 2001;162(2):108-20.
26. Pinelli E, Killick-Kendrick R, Wagenaar J, Bernadina W, del Real G, Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect Immun 1994;62(1):229-35.
27. Santos-Gomes GM, Rosa R, Leandro C, Cortes S, Romao P, Silveira H. Cyokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet Immunol Immunopathol 2002;88:21-30.
28. Pinelli E, Rutten VPMG, Bruysters M, Moore PF, Ruitenberg EJ. Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production. Infect Immun 1999;67(1):237-43.
29. Abranches P, Santos-Gomes G, Rachamim N, Campino L, Schnur L, Jaffe CL. An experimental model for canine leishmaniasis. Parasite Immunol 1991;13(5):537-50.
30. Bourdoiseau G, Bonnefont C, Magnol JP, Saint-Andre I, Chabanne L. Lymphocyte subset abnormalities in canine leishmaniasis. Vet Immunol Immunopathol 1997;56:345-51.
31. Moreno J, Nieto J, Chamizo C, Gonzalez F, Blanco F, Barker DC, et al. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet Immunol Immunopathol 1999;71:181-95.
32. Bourdoiseau G, Bonnefont C, Hoareau E, Boehringer C, Stolle T, Chabanne L. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Vet Immunol Immunopathol 1997;59:21-30.
33. Leandro C, Santos-Gomes GM, Campino L, Romao P, Cortes S, Rolao N, et al. Cell-mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniasis. Vet Immunol Immunopathol 2001;79:273-84.
34. Solano-Gallego L, Riera C, Roura X, Iniesta L, Gallego M, Valladares JE, et al. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Vet Parasitol 2001;96(4):265-76.
35. Reithinger R, Quinnell RJ, Alexander B, Davies CR. Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. Clin Microbiol 2002;40(7): 2352-6.
36. Badaro R, Benson D, Eulalio MC, Freire M, Cunha S, Netto EM. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 1996; 173(3):758-61.
37. Riera C, Valladares JE, Gallego M, Aisa MJ, Castillejo S, Fisa R, et al. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Vet Parasitol 1999;84:33-47.
38. Reale S, Maxia L, Vitale F, Glorioso NS, Caracappa S, Vesco G. Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood. J Clin Microbiol 1999; (9)37:2931-5.
39. Leontides LS, Saridomichelakis MN, Billinis C, Kontos V, Koutinas AF, Galatos AD, et al. A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece. Vet Parasitol 2002;109:19-27.
40. Ashford DA, Bozza M, Freire M, Miranda JC, Sherlock I, Eulalio C, et al. Comparison of the polymerase chain reaction and serology for the detection of canine visceral leishmaniasis. Am J Trop Med Hyg 1995;53(3):251-5.
41. Lamothe J. Treatment of canine leishmaniasis from A (Amphotericin B) to Z (Zyloric). In: Killick-Kendrick R, Editor. canine leishmaniasis: an update. Proceedings of the International Canine Leishmania Forum Barcelona (Spain): Hoechst Roussel Vet.; 1999. p. 12-7.
42. Baneth G, Shaw SE. Chemotherapy of canine leishmaniasis. Vet Parasitol 2002;106(4): 315-24.
43. Cavaliero T, Arnold P, Mathis A, Glaus T, Hofmann-Lehmann R, Deplazes P. Clinical, serologic, and parasitologic follow-up after long-term allopurinol therapy of dogs naturally infected with Leishmania infantum. J Vet Intern Med 1999;13(4):330-4.
44. Koutinas AF, Saridomichelakis MN, Mylonakis ME, Leontides L, Polizopoulou Z, Billinis C, et al. A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniasis. Vet Parasitol 2001;98(4):247-61.
45. Ginel PJ, Lucena R, Lopez R, Molleda JM. Use of allopurinol for maintenance of remission in dogs with leishmaniasis. J Small Anim Pract 1998;39(6):271-4.
46. Killick-Kendrick R, Killick-Kendrick M, Focheux C, Dereure J, Puech MP, Cadiergues MC. Protection of dogs from bites of phlebotomine sand flies by deltamethrin collars for control of canine leishmaniasis. Med Vet Entomol 1997;11(2):105-11.
47. Halbig P, Hodjati MH, Mazloumi-Gavgani AS, Mohite H, Davies CR. Further evidence that deltamethrin-impregnated collars protect domestic dogs from sand fly bites. Med Vet Entomol 2000;14(2):223-6.
48. Maroli M, Mizzon V, Siragusa C, D'Oorazi A, Gradoni L. Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med Vet Entomol 2001;15(4):358-63.
49. Gavgani AS, Hodjati MH, Mohite H, Davies CR. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002;360(9330):374-9.
50. Gradoni L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Vet Parasitol 2001;100:87-103.
51. Handman E. Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 2001;(2):229-43.
52. da Silva VO, Borja-Cabrera GP, Correia Pontes NN, de Souza EP, Luz KG, Palatnik M, et al. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN). Vaccine 2000;19:1082-92.
53. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996;55(2): 125-30.
54. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 2002;186(9):1314-20.
55. Anderson DC, Buckner RG, Glenn BL, MacVean DW. Endemic canine leishmaniasis. Vet Pathol 1980;17(1):94-6.
56. Kocan KM, MacVean DW, Fox JC. Ultrastructure of Leishmania sp. isolated from dogs endemic in Oklahoma. J Parasitol 1983;69(3):624-6.
57. Swenson CL, Silverman J, Stromberg PC, Johnson SE, Wilkie DA, Eaton KA, et al. Visceral leishmaniasis in an English foxhound from an Ohio research colony. J Am Vet Med Assoc 1988;193(19):1089-92.
58. Sellon RK, Menard MM, Meuten D, Lengerich EJ, Steurer FJ, Breitschwerdt EB. Endemic visceral leishmaniasis in a dog from Texas. J Vet Intern Med 1993;7(1):16-19.
59. Eddlestone SM. Visceral leishmaniasis in a dog from Maryland. J Am Vet Med Assoc 2000;217(11):1686-8.
60. Schantz P. Canine visceral leishmaniasis in North America: Current status of epidemiological investigation [abstract]. In: Proceedings of the American Association of Veterinary Parasitologists 47th annual meeting. Nashville (TN): American Association of Veterinary Parasitologists; 2002. p. 58-9.
61. Rosypal AC, Lindsay DS, Zajac AM, Duncan RB. Responses of normal and cytokine deficient (iNOS and INF-gamma) mice to infection with an American isolate of Leishmania infantum [abstract]. In: Proceedings of the American Association of Veterinary Parasitologists 47th annual meeting. Nashville (TN): American Association of Veterinary Parasitologists; 2002. p. 44.
62. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interactions: immunopathogenic mechanisms. Parasitol Today 1999;15(5):182-7.
63. Desjeux P. Global control and Leishmania HIV coinfection. Clin Dermatol 1999;17(3): 317-25.
64. Alvar J, Cañavate C, Gutiérrez-Solar B, Jiménez M, Laguna F, López-Vélez R, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997;10(2):298-319.
65. Pintado V, Martín-Rabadán P, Riviera ML, Moreno S, Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: a comparative study. Medicine (Baltimore) 2001;80(1):54-73.
66. Kager PA. Leishmania species (leishmaniasis). In: Yu VL, Weber R, Raoult D, editors. Antimicrobial therapy and vaccines. Volume 1: microbes. 2nd edition. New York: Apple Tree Productions; 2002. p. 1555-80.
67. Kaplan J, Hanson D, Dworkin M, Frederick T, Bertolli J, Lindegren M, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30(Suppl 1):S5-14.
68. de la Rosa R, Pineda J, Delgado J, Macías J, Morillas F, Mira J, et al. Incidence and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy. J Clin Microbiol 2002;40(3):762-7.
69. del Guidice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, et al. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus. J Infect Dis 2002;186(9):1366-70.